Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > On-Demand Supplier Webinar

Using FDA’s Draft Guidance on Risk-Based Monitoring to Improve Clinical Data Quality

Published: 11-Oct-2012 | Format: Webinar | Document type: Supplier Webinar
Related applications: Data management , Phase I-II , Phase III-IV

The Industry’s changing approach to clinical data monitoring requires the tools and team structure to effectively plan and execute risk-based monitoring. Join Lynn King and Rob Woolson as they discuss multi-disciplinary approaches to implementing alternative monitoring plans and specialized tools for successfully executing risk-based monitoring.

Speakers:

  • Lynn King, Assistant Vice President, Operations, Rho

    Lynn King

    Assistant Vice President, Operations

    Rho

  • Rob Woolson, MS, Senior Biostatistician, Rho

    Rob Woolson, MS

    Senior Biostatistician

    Rho

Fill Form to Watch Now!

*
*
*
*
*
*
*
*

Please note that any information that you supply is protected by our Privacy and Cookie Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.